Concepedia

Philip Klövekorn

PK

4

Publications

102

Citations

4

H-Index

2019

Active since

Affiliations

German Cancer Research Center(Current)

Heidelberg University

TU Dortmund University

University of Tübingen

Lead Discovery Center (Germany)

Philip Klövekorn is an author at German Cancer Research Center specializing in drug discovery, medicine, and medicinal chemistry.

Top concepts

MedicinePharmacologyDrug DiscoveryMedicinal ChemistryChemical BiologyNatural SciencesBiomolecular EngineeringCell SignalingSmall MoleculesDrug Development

Publications per year

2019–2021

4

Publications

4

Inhibition of osimertinib-resistant epidermal growth factor receptor EGFR-T790M/C797S

Jonas Lategahn, Marina Keul, Philip Klövekorn et al. · Chemical Science · 2019 · 48 citations · Full text

Design and synthesis of 1H-pyrazolo[3,4-b]pyridines targeting mitogen-activated protein kinase kinase 4 (MKK4) - A promising target for liver regeneration

Bent Pfaffenrot, Philip Klövekorn, Michael Juchum et al. · European Journal of Medicinal Chemistry · 2021 · 22 citations · Full text

Medicinal Chemistry, Natural Sciences, Drug Discovery +9

Targeting Her2-insYVMA with Covalent Inhibitors—A Focused Compound Screening and Structure-Based Design Approach

Jonas Lategahn, Julia Hardick, Tobias Grabe et al. · Journal of Medicinal Chemistry · 2020 · 17 citations · Full text

Molecular Biology, Chemical Biology, Pharmaceutical Chemistry +19

From off-to on-target: New BRAF-inhibitor-template-derived compounds selectively targeting mitogen activated protein kinase kinase 4 (MKK4)

Philip Klövekorn, Bent Pfaffenrot, Michael Juchum et al. · European Journal of Medicinal Chemistry · 2020 · 15 citations · Full text

New Braf-inhibitor-template-derived, Medicinal Chemistry, Drug Target +11

Rows per page

1–4 of 4